Chemosensitivity testing is a laboratory-based diagnostic examination designed to assess how a patient’s cancer cells respond to different treatment options before they are administered. The analysis is performed on circulating tumor cells (CTCs) isolated from the patient’s blood sample under controlled laboratory conditions. The test does not involve administering any medications or substances to the patient. The results provide additional information that may be used to support individualized planning of further medical treatment.
Response to oncological treatment can vary between patients even when the diagnosis is the same, which is a well-recognized phenomenon in oncology. For this reason, therapeutic decisions require consideration of multiple clinical factors. Chemosensitivity testing is intended to complement this assessment by analysing how cancer cells respond to a broad range of treatment options under laboratory conditions.
The scope of the analysis includes:
Chemosensitivity testing is a laboratory-based diagnostic examination designed to assess how a patient’s cancer cells respond to different treatment options before they are administered.
The analysis is performed on circulating tumor cells (CTCs) isolated from the patient’s blood sample under controlled laboratory conditions. The test does not involve administering any medications or substances to the patient. The results provide additional information that may be used to support individualized planning of further medical treatment.
Response to oncological treatment can vary between patients even when the diagnosis is the same, which is a well-recognized phenomenon in oncology. For this reason, therapeutic decisions require consideration of multiple clinical factors.
Chemosensitivity testing is intended to complement this assessment by analysing how cancer cells respond to a broad range of treatment options under laboratory conditions.
The scope of the analysis includes:
Chemosensitivity testing may be considered:
The decision to perform chemosensitivity testing is made by a doctor, taking into account the patient’s diagnosis, medical history, clinical situation, and current oncological guidelines.
Multilingual care
Our staff speaks English, Polish, and German.
The test results are reviewed by a doctor, taking into account your overall health, medical history, and any other relevant clinical information.
During a medical consultation, the results are explained and discussed to ensure they are properly understood and interpreted within the appropriate clinical context.
Fasting is not required. You may eat and drink normally before the blood sample is taken, unless your doctor advises otherwise.
Please inform the doctor about all medications you are currently taking. Based on your individual situation, the doctor will advise you on whether any changes are required prior to testing.
A chemosensitivity test may be considered in various types of cancer, provided that circulating tumor cells (CTCs) are present in the blood and appropriate clinical indications exist. The suitability and potential benefit of the test in each individual case are always assessed by a doctor.
The test may be performed at various stages of the disease, provided that circulating tumor cells (CTC) are present in the bloodstream and there is a clinical indication for the analysis.
Once the blood sample reaches the laboratory, the report is usually available within approximately 7–10 working days.
Of course! We will be happy to assist with arranging both accommodation and transportation. We work with trusted hotels located near our clinic and can also organize airport transfers from Munich. Please contact our team — we will be glad to present the available options and help you choose the solution best suited to your needs.